Breast Cancer Drug May Cause Sexual Dysfunction

BCS_Blog_DTOP_BelowTitle_336x280

EmaxHealth Health News

By Robin Wulffson MD for eMaxHealth.com

A new study by Swedish researchers has reported that certain hormone-blocking drugs to reduce the risk of breast cancer recurrences impact a woman’s sex life. Researchers affiliated with Örebo University Hospital (Örebo, Sweden) published their findings online on September 17 in the journal Menopause.

The goal of the study was to evaluate the effect of aromatase inhibitors on the sexual function of postmenopausal breast cancer patients. Aromatase is the enzyme which manufactures estrogen. Many breast and ovarian cancers require estrogen to grow; thus, aromatase inhibitors are taken to either block the production of estrogen or block the action of estrogen on receptors.

Learn more.

Lockerdome BCS – desktop
Medianet BCS
The Breast Cancer Site is a place where supporters and survivors come together to help fight breast cancer. In addition to sharing personal stories of hope, shopping for the cause, and signing petitions, visitors can take just a moment each day to click on a pink button to provide free mammograms for women in need. Visit The Breast Cancer Site and click today - it's free!